Pradžia › Folikulinė limfoma › Florida

Folikulinė limfoma klinikiniai tyrimai Florida

25 tyrimai dėl Folikulinė limfoma ieško dalyvių vietose Florida.

Miestai Florida

Oficialus tyrimo tekstas (anglų kalba)

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
ir dar 6

Renkami dalyviai3 fazė

Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07215910

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Mayo Clinic Jacksonville, Jacksonville
Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Tampa General Hospital Cancer Institute, Tampa

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT05006716

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Moffitt Cancer Center, Tampa

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06350318

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

University of Miami - Sylvester Cancer Center, Miami
Florida Cancer Specialists - Sarasota, Sarasota

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07226843

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Research Site, Jacksonville

Renkami dalyviai3 fazė

Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, Tampa

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06526793

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Mayo Clinic Jacksonville, Jacksonville
AdventHealth, Orlando

Renkami dalyviai3 fazė

Amžius nuo 12 iki 100 · Visoms lytims · Atnaujinta 2026-09-11 · NCT06784752

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
ir dar 6

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06860594

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Research Site, Miami Lakes

Renkami dalyviai1 fazėLaukiami sveiki savanoriai

Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07546760

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

University of Florida Health, Gainesville
Mayo Clinic - Florida, Jacksonville
University of Miami Health, Miami
ir dar 1

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT05303519

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Boca Raton Clinical Research (BRCR) Global, Plantation

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT06149286

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Gateway Community Services, Jacksonville
IBIS Behavioral Health, Tampa

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT06651177

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

Renkami dalyviai1/2 fazė

Amžius nuo 13 iki 90 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06533579

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Mayo Clinic, Jacksonville

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-30 · NCT07424833

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

University of Miami, Miami
Florida Cancer Specialists, Sarasota

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT05131022

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

UF Health, Gainesville

Renkami dalyviai1 fazė

Amžius 4 ir vyresni · Visoms lytims · Atnaujinta 2026-06-25 · NCT04573140

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Orlando Clinical Research Center, Orlando

Renkami dalyviai1 fazė

Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-06-16 · NCT07559474

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Local Institution - 0008, Jacksonville
Local Institution - 0214, Tampa
Local Institution - 0217, Tampa

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-20 · NCT06911502

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

ASCLEPES Research Centers, Weeki Wachee

Renkami dalyviai1/2 fazė

Amžius nuo 12 iki 95 · Visoms lytims · Atnaujinta 2026-04-15 · NCT04329728

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Florida Cancer Specialists and Research Institute, Fort Myers
University of Miami, Miami

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-23 · NCT04998669

Study of SGR-1505 in Mature B-Cell Neoplasms

Napa Research, Pompano Beach

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT05544019

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

Mayo Clinic in Florida, Jacksonville

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT06191887

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Mount Sinai Comprehensive Cancer Center, Miami Beach
Moffitt Cancer Center, Tampa

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-10 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Jacksonville
Massive Bio SYNERGY-AI site, Miami
Massive Bio SYNERGY-AI site, Tampa

Renkami dalyviaiStebimasis tyrimas

Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Florida Cancer Specialists, Sarasota

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-02 · NCT05780034

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.